
North America Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Description
North America Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $459.6 billion in 2022, representing a compound annual growth rate (CAGR) of 4.2% between 2017 and 2022.
- 0
- The US acquired an 88.8% share of the North American pharmaceuticals market in 2022. The FDA regulates the pharmaceutical industry in the US, approving 12% of drugs submitted for clinical testing annually. The rigorous clinical trial process results in additional spending on research and development.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the North America pharmaceuticals market by value in 2022?
- What will be the size of the North America pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up North America's pharmaceuticals market?
Table of Contents
49 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Johnson & Johnson
- 8.2. Pfizer Inc.
- 8.3. Merck & Co., Inc.
- 8.4. AstraZeneca PLC
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: North America pharmaceuticals market value: $ billion, 2017-22
- Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: North America pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Johnson & Johnson: key facts
- Table 5: Johnson & Johnson: Annual Financial Ratios
- Table 6: Johnson & Johnson: Key Employees
- Table 7: Johnson & Johnson: Key Employees Continued
- Table 8: Pfizer Inc.: key facts
- Table 9: Pfizer Inc.: Annual Financial Ratios
- Table 10: Pfizer Inc.: Key Employees
- Table 11: Pfizer Inc.: Key Employees Continued
- Table 12: Merck & Co., Inc.: key facts
- Table 13: Merck & Co., Inc.: Annual Financial Ratios
- Table 14: Merck & Co., Inc.: Key Employees
- Table 15: Merck & Co., Inc.: Key Employees Continued
- Table 16: AstraZeneca PLC: key facts
- Table 17: AstraZeneca PLC: Annual Financial Ratios
- Table 18: AstraZeneca PLC: Key Employees
- Table 19: AstraZeneca PLC: Key Employees Continued
- Table 20: North America exchange rate, 2018-22
- List of Figures
- Figure 1: North America pharmaceuticals market value: $ billion, 2017-22
- Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: North America pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.